Disc Medicine
IRON
57 hedge funds and large institutions have $39.6M invested in Disc Medicine in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.3% less ownership
Funds ownership: 2.49% → 2.2% (-0.3%)
8% less funds holding
Funds holding: 62 → 57 (-5)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
43% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 23
58% less capital invested
Capital invested by funds: $93.8M → $39.6M (-$54.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$593K |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$350K |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$173K |
| 4 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
+$116K |
| 5 |
CM
Crestline Management
Fort Worth,
Texas
|
+$109K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.6M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$2.52M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.85M |
| 4 |
JCM
JS Capital Management
New York
|
-$1.38M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$573K |
IRON Hedge Fund Activity: Q1 2022 in Review
57 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q1 2022, worth a combined $39.6M — down 58% from $93.8M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of IRON and 8 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 13 added.
The largest buyer was Renaissance Technologies, adding an estimated $593K. The largest seller was Fidelity Investments, cutting an estimated $2.6M.
- 57 institutional investors held Disc Medicine (IRON) as of Q1 2022, down from 62 in Q4 2021.
- Funds reported $39.6M of Disc Medicine stock for Q1 2022, down 58% quarter-over-quarter.
- 8 funds opened new Disc Medicine positions in Q1 2022 and 13 closed out, a net change of -5 holders.
- The largest Disc Medicine buyer in Q1 2022 was Renaissance Technologies, an estimated $593K added.
- The largest Disc Medicine seller in Q1 2022 was Fidelity Investments, an estimated $2.6M sold.
Based on aggregated 13F filings for Q1 2022.